Geron Announces September Investor Conference Presentation Webcasts
Geron Corporation (NASDAQ: GERN) announced that Dr. John A. Scarlett, its Chairman and CEO, will present at three upcoming investor conferences in September 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
-
H.C. Wainwright 23rd AnnualGlobal Virtual Investment Conference onMonday, September 13, 2021 at7:00 a.m. ET . -
R.W. Baird 2021Virtual Global Healthcare Conference onTuesday, September 14, 2021 at2:00 p.m. ET . -
2021
Cantor Virtual Global Healthcare Conference onThursday, September 30, 2021 at3:20 p.m. ET .
A live webcast of each presentation will be available through the Investor Relations section of Geron’s website under Events. Following the presentations, the webcasts will be archived and available for replay for a period of 30 days.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company currently is conducting two Phase 3 clinical trials:
View source version on businesswire.com: https://www.businesswire.com/news/home/20210901005369/en/
Chief Financial Officer
investor@geron.com
media@geron.com
Source: